Anti-EPSTI1 monoclonal antibody

Pre-made anti-EPSTI1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EPSTI1/EPSTI1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0763-Ab-1/ GM-Tg-hg-IP0763-Ab-2Anti-Human EPSTI1 monoclonal antibodyHuman
GM-Tg-rg-IP0763-Ab-1/ GM-Tg-rg-IP0763-Ab-2Anti-Rat EPSTI1 monoclonal antibodyRat
GM-Tg-mg-IP0763-Ab-1/ GM-Tg-mg-IP0763-Ab-2Anti-Mouse EPSTI1 monoclonal antibodyMouse
GM-Tg-cynog-IP0763-Ab-1/ GM-Tg-cynog-IP0763-Ab-2Anti-Cynomolgus/ Rhesus macaque EPSTI1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0763-Ab-1/ GM-Tg-felg-IP0763-Ab-2Anti-Feline EPSTI1 monoclonal antibodyFeline
GM-Tg-cang-IP0763-Ab-1/ GM-Tg-cang-IP0763-Ab-2Anti-Canine EPSTI1 monoclonal antibodyCanine
GM-Tg-bovg-IP0763-Ab-1/ GM-Tg-bovg-IP0763-Ab-2Anti-Bovine EPSTI1 monoclonal antibodyBovine
GM-Tg-equg-IP0763-Ab-1/ GM-Tg-equg-IP0763-Ab-2Anti-Equine EPSTI1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0763-Ab-1/ GM-Tg-hg-IP0763-Ab-2; GM-Tg-rg-IP0763-Ab-1/ GM-Tg-rg-IP0763-Ab-2;
GM-Tg-mg-IP0763-Ab-1/ GM-Tg-mg-IP0763-Ab-2; GM-Tg-cynog-IP0763-Ab-1/ GM-Tg-cynog-IP0763-Ab-2;
GM-Tg-felg-IP0763-Ab-1/ GM-Tg-felg-IP0763-Ab-2; GM-Tg-cang-IP0763-Ab-1/ GM-Tg-cang-IP0763-Ab-2;
GM-Tg-bovg-IP0763-Ab-1/ GM-Tg-bovg-IP0763-Ab-2; GM-Tg-equg-IP0763-Ab-1/ GM-Tg-equg-IP0763-Ab-2
Products NameAnti-EPSTI1 monoclonal antibody
Formatmab
Target NameEPSTI1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EPSTI1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0763-Ag-1Recombinant multi-species ESIP1/ EPSTI1/ BRESI1 protein


    Target information

    Target IDGM-IP0763
    Target NameEPSTI1
    Gene ID94240,108670,498547,700208,476931,101089570,614555,100051337
    Gene Symbol and Synonyms2310046K10Rik,5033415K03Rik,BRESI1,EPSTI1,RGD1563207
    Uniprot AccessionQ96J88,Q5BK43
    Uniprot Entry NameESIP1_HUMAN,ESIP1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000133106
    Target ClassificationN/A

    The target: EPSTI1, gene name: EPSTI1, also named as BRESI1. The protein encoded by this gene has been shown to promote tumor invasion and metastasis in some invasive cancer cells when overexpressed. Expression of this gene has been shown to be upregulated by direct binding of the Kruppel like factor 8 protein to promoter sequences. The translated protein interacts with the amino terminal region of the valosin containing protein gene product, resulting in the nuclear translocation of the nuclear factor kappa B subunit 1 gene product, and activation of target genes. Overexpression of this gene has been observed in some breast cancers and in some individuals with systemic lupus erythematosus (SLE). [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.